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Guanylin is a manmalian peptide homologue of beat-stable enterotoxins that acts on inustinal gtumylate cyclasc to elicit an increase in cyclic GMP. 
We have isolated a cDNA cncodinp an apparent precursor of guanylin from a human intestinal cDNA library. The mRNA is expressed al high 
levels in human ileum and colon. Human guanylin stimulated increases inT84 celt cyclic GMP Icvels, displaced ‘2Sf-labelled heat-stable enterotoxin 
(S-l%) binding to this cell line, and stimulaled increases in short-circuit current (1s~) of isolated rat proximal colonic mucosa. This peptidc may play 
a role in regulating fluid and eleclrolyte absorption in human inteslines. 
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1, INTRODUCTION 
The recent discovery of the intestinal peptide, gua- 
nylin, from the rat jejunum has provided evidence for 
a new intestinal paracrine/endocrine system that acts, in 
part, through the second messenger, cyclis GMP [l]. 
Guanylin apparently acts on the isoform of guanylate 
cyciase, termed @C-C or intestinal guanylate cyclase, to 
increase intestinal epithelial cell cyclic GMP levels [I] 
and thus regulate intestinal fluid and electrolyte absorp 
tion through the second messenger, cyclic GMP. lntesti- 
nal guanylate cyclase has for many years been known 
to be a target for the heat-stable cnterotoxins (STs) [2,3]. 
The peptide sequence of rat guunylin is similar to that 
of the STs, and it competes for the same intestinal bind- 
ing sites [I]. Purified rat guanylin is an acidic pcptide 15 
amino acids in length. The peptide is characterized by 
the presence of 4 cysteines that require oxidation and 
disulfide bridge formation for full expression of activity 
[I]. Cloning of rat guanylin indicated that this peptide 
is derived from the processing of a I 15 amino acid 
containing precursor encoded on a 600 base mRNA 
14351. 
The mechanism of STs’ actions on intestinal fluid and 
electrolyte transport is thought o occur through activa- 
tion of the guanylin receptor (intestinal guanylate 
cyclase) by binding of the toxin. This elicits an increase 
in cyclic GMP that mediates the increase in chloride 
secretion and the decrease in sodium and water absorp- 
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tion [2,3,6]. The net effect of these actions in the intes- 
tine is to cause a secretory diarrhea 173. In developing 
countries, the diarrhea caused by the family of heat- 
stable enterotoxins is thought to be a major cause of 
death in the infant population [7,5]. Meat-stable entero- 
toxins appear to mimic guanylin to activate intestinal 
guanylate cyclase and produce their pathogenic effect. 
2. MATERIALS AND METHODS 
A human duodenum cDNA library in LgtlO obtained from Clon- 
tech (Palo Alto, CA) was screened under low stringency hybridization 
conditions [9]. The filters wcrc probed using purilied insert from 
pMON9022, the rat guanylin cDNA [4], labeled with ;?P by random 
priming. Adult human intestinal RNAs were the generous gift of Dr. 
Burton Wice and were described in [IO]. Northern blots [9] were 
hybridized with a full-length uman guanylin cDNA insert which bud 
been labrled by random priming. 
2.2 Pepride synthesis 
Human guanylin,,,.,,, was synthesized by the solid-phase method 
with an Applied Biosystems 430A peptide synthesizer essentially as 
described previously [I]. Tbe structures and purity of the synthetic 
peptides were verified by thcrmospraylmass spectroscopy, amino acid 
analysis. and gas-phase sequence analysis. 
2.3. Biofugicul cissu_vs 
Cyclic GMP and binding assays were done as described previously 
[I], For binding, the results arc expressed as the percentage of 
[‘251]STaS_,n specifically bound. For short circuit current 
measurenxnts, proximal colon tissue, consisting of only mucosa and 
submucosa, was mounted bctwccn two Ussing half-chambers and 
bathed on both sides. Electrical measurements were monitored with 
an automaiic voltage clamp nnd direct connecting voltage- and cur- 
rent-passing electrodes were utilized to measure trans.epithelial poten- 
hl difference and siiur1-&l*cuit current. Tissues were equilibrated 
under short-circuit conditions until short-circuit current had stabilized 
(usually 30-45 min). Basal tissue resistance values averaged 44 t 4 
Y/cm” (tt = IO) 30 min iiftcr mounting. 
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3. RESULTS 
We have used relaxed stringency hybridization to iso- 
late a human homologue of the rat guanylin gene. A 
full-length rat cDNA fragment was used as a probe to 
screen a cDNA library made from human duodenum 
RNA. Thirty-six positive phages were identified and 
plaque purified by two subsequent rounds of plating 
and screening. DNA was prepared from each of these 
positive clones and analyzed by restriction mapping and 
Southern blotting. Eleven of the clones remained posi- 
tive on the Southern blots when probed with the rat 
guanylin cDNA insert, as described above, and washed 
at high stringency. When labeled insert From one of 
these 11 clones was used to probe all 36 ;I DNA isolates 
on a Southern blot under high stringency the same 1 I 
clones hybridized. lnserts from four of these clones were 
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subcloned into pGEM7 for sequencing, whilst the end 
points of the rest were sequenced irectly in the ;i DNA. 
The 589 bp sequence obtained from these clones is 
shown in Fig. 1. The cDNAs obtained are large enough 
to be near full-length clones of the mRNA (see below), 
The complete sequence given was determined in three 
non-sibling clones. 
By Northern blot analysis, the human guanylin 
mRNA ran as a single, somewhat diffuse, species of 
about 600 bases in len@h. tike rat guanylin, the human 
guanylin mRNA is expressed preferentially in the distal 
regions of the cephalocaudal xis of the gut (Fig. 2). The 
highest levels of expression are observed incolon and 
ileum, lower levclsinjejunum and duodenum, and the 
message is undetectable in stomach. 
To confirm the identity of this @tie and assess 
its biological activity we synthesized the homologue 
. 
TCGCTGCCA~G~TGCCTT~~TGCTCTTCGOACTGTGCCTC~TTGGGGC~TGGGCCGCC 
M etAs~aLeuCvsZe~@uGlvAlaTr~A~aA~~ nA 
. . . 
~TGGCAGGAG~GGTCACCGTGCAGGATGG~TTTCTC~TTTT~T~TGGA~TCAGTG~G 
LeuAlaGlyGlyValThrValGlnAspGlyA~nPheS~rPheS~rL~uGluS~rVal~ 
. . 
CTCAAGCCTCTCTGCAAGGAGCCCAATGCCCAGGAGATACTTCAGAGGCT~GAGG~TC 
LeuLysProLeuCysLysGluProAsnAlaGlnGluIleL~uGlnArgLeuGluGluIle 
. . 
GGCTTGCCCA~TGCCTGCCTCCCCTCCGCA~CAGGGaAGCTCTTTTCTCC~GCAG~GG 
. 
CA~CCCCCAG~T~~ATAAACCAGATTC~AGAGT A 
Fig. I. Sequence of the human guanylin cDNA. The guanylin sequrnce is indicated by a double underline; the possible leader sequence, th  Lys-Lys 
site and the polyadcnylation signals are 311 indicated by single underlines. The Gcnllank accession umber for lhis wqucncc is M97496. 
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Fig. 2. Guanylin steady-state mRNA levels in human gastrointestinal 
tract by Northern blot analysis. The RNA in the respective lanes (10 
,uug) nre: colou (C), ileum (I), jcjunum (J), duodenum (D) and stomach 
(3. 
of the I5 amino acid rat guanylin peptide, human 
guanylinlO,_,,,. Chemical synthesis of the bioactive spe- 
cies in high yield required sequential deprotection and 
oxidation of the cysteine disulfide pairs to force pairing 
of Cys-4 with Cys-12 and Cys-7 with Cys-15. Air oxida- 
tion of 5 peptide with all four cysteinsa ucprotected 
produced a mixture of isomers, with the correctly folded 
form representing only a small Fraction of the total ma- 
terial (data not shown), 
Synthetic human guanylin caused a concentration- 
dependent increase in T84 cell cyclic GMP (Fig. 3A). 
Human guanylin and rat guanylin had a similar relative 
potency for activation of intestinal guanylate cyclase. 
Both were about one order of magnitude less potent 
than STa. A similar profile of relative potency for dis- 
placing [1151]-STa5_,U specific binding from T84 cells was 
also observed with STa the most potent, and human and 
rat guanylin somewhat less potent (Fig, 3B). The data 
indicate that while heat-stable nterotoxin is more po- 
tent at stimulating intestinal guanylate cyclase, all of 
these peptides hare common binding sites. 
To assess the effects of human guanylin on intestinal 
function it was tested on isolated rat proximal colon 
mounted in Ussing chambers. In these experiments, the 
measurement of short-circuit current (1s~) is used as an 
indicator of chloride secretion. Previous studies have 
indicated that the change in Isc elicited by STa and rat 
guanylin is, for the most part, accounted for by a stim- 
u&ion of chloride secretion [2,3,1 I]. Human glrn@in 
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Fig. 3. Comparison of the effects of STa5_,,, human glanylin and rat 
puanylin on T84 cyclic GMP levels and [‘z51]STa3_,s binding. (A) Effect 
of increasing concentrations of STa, human guanylin and T;LL guanylin 
on intracellular cyclic GMP levels in T84cells. Values represent means 
f S.E.M. (n = 6). (l3) Competitive inhibition of ~“SIjSTa5_l, binding 
by unlabeled STa5_,,, (0). human guanylin (0) or rat guanylin (A) in 
T84 cells. Each point rcprcsents he mean of triplicate determinations. 
Similar results were obtained in two additional experiments. 
was added to the mucosal side in increasing concentra- 
tions in a cumulative manner. Human guanylin stimu- 
lated an increase in Isc with an ECso of 30 nM (Fig. 4), 
which is similar to that recently reported for rat gua- 
nylin and STa [l l’J, The maximal increase in Isc of 491-4 
,uA!cm’ is similar to maximal effects elicited by rat gua- 
nylin and STa in the proximal colon [l 13. 
4. DISCUSSION 
The cDNA sequence encodes an apparent pre- 
prohormone of 115 amino acids. The open reading 
frame, beginning with the only in-frame methionine in 
the cDNA, encodes a peptide that shares 14 of 15 amino 
acids with rat guanylin at its C-terminal end. The rat 
anti human cDNAs share a striking 65-70% identity 
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Fig. 4, Effects of increasing concentrations of human guanylin on 
short-circuit current (1s~) across rat proximal colonic mucosa. All 
additions were made from the rnucosal side and the values represent 
the mean 4 S.E.M of 8 determinations from 4 animals. 
overall in both the DNA and protein sequences (Fig. 5) 
and have their major structural features in common. 
The N-terminus is hydrophobic, which is consistent 
with a leader sequence, and there is a polyadenylation 
signal and poly-A tail at the 3’ end of the mRNA. There 
is one dibasic pair (Lys-Lys) which might be used for 
processing, although the location of this sequence is not 
conserved between rat and human. A 15 amino acid 
peptide analogous to rat guanylin would result from 
cleavage between Asp and Pro at position 100 of the 
precursor, just as it would in the rat. 
Interestingly, the guanylin precursors also share some 
structural similarity with the STa precursors identified 
in E. coli [12,13]. Both STa and guanylin are encoded 
on relatively small precursor proteins, 72 amino acids 
for STa vs. 115 for guanylin, which contain a typical 
secretion leader. In each case the identified active pep- 
tide is encoded in the C-terminal residues of the precur- 
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sor. Both precursors contain Lys-Lys dibasic sites, 
though in neither case is there yet evidence for process- 
ing at those sites. The highest sequence conservation 
exists between the active peptides and, most impor- 
tantly, the positions of the cysteine residues and the 
pattern of disulfide linkage are conserved between the 
STa and guanylin peptides. 
We found that human guanylin stimulates an increase 
in cyclic GMP in TS4 cells in a manner similar to that 
of rat guanylin and heat-stable enterotoxin. Human and 
rat guanylin also displaced the specific binding of ST to 
T84 cells. Potency comparisons indicate little difference 
between human and rat guanylin in regard to their effect 
on TS4 cyclic GMP and displacement of ST binding. 
These results also indicated that the toxin is more potent 
than these synthetic I5 amino acid forms of guanylin. 
Human guanylin stimulated aconcentration-dependent 
increase in short-circuit current in the proximal rat 
colon mounted in a Ussing chamber. This change in 
short circuit current in the proximal rat colon is thought 
to be due, in large part, to a stimulation of chloride 
secretion [2,3,1 I]. These studies indicate that guanylin 
acts in a manner similar to ST, and therefore would be 
expected to cause the secretion of chloride and fluids 
through a cyclic GMP-dependent mechanism. 
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